Atrial Fibrillation New Onset Clinical Trial
Official title:
Usefulness of Amiodarone for the Prevention of New Onset Atrial Fibrillation After Transcatheter Aortic Valve Implantation: a Randomized Controlled Trial
New onset atrial fibrillation (NOAF) is a relatively frequent complication after
transcatheter aortic valve implantation (TAVI). This complication has been related with worse
short and long-term outcomes, including higher stroke, mortality, readmission and bleeding
rates. The aim of this study is to evaluate the effectiveness of amiodarone in the prevention
of the NOAF after TAVI.
The study is a multicenter, randomized double-blinded trial including 120 patients without
prior AF that will undergo TAVI in a scheduled basis. Patients will be randomized to be
treated with amiodarone orally from 6 days before to 6 days after the TAVI procedure versus
placebo.
All the patients will be monitored with a 60-day holter to evaluate NOAF incidence. The main
objective is NOAF incidence after TAVI at 30-day. Secondary endpoints are the incidence of
NOAF, stroke, bleeding and all-cause and cardiovascular mortality in both groups at 60-day.
Results of this study can contribute to optimize TAVI results in a short and long term,
potentially improving the survival and quality of life in this group of frail patients with
comorbidities, which makes them vulnerable to NOAF, stroke, bleeding, heart failure and
readmission.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06055751 -
Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
|
||
| Recruiting |
NCT04870424 -
Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
|
Phase 3 | |
| Completed |
NCT05818592 -
Screening for Atrial Fibrillation With Self Pulse Monitoring
|
N/A | |
| Active, not recruiting |
NCT05780320 -
A Pharmaco-surgical Approach to Reduce Postoperative Atrial Fibrillation After Cardiac Surgery
|
||
| Active, not recruiting |
NCT03866148 -
Obstructive Sleep Apnoea and Cardiac Arrhythmias
|
N/A | |
| Withdrawn |
NCT05656170 -
Stellate Ganglion to Prevent Atrial Fibrillation
|
N/A | |
| Active, not recruiting |
NCT05255224 -
PARADISE: Predicting AF After Cardiac Surgery
|
||
| Recruiting |
NCT04528511 -
BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction
|
||
| Recruiting |
NCT04857268 -
Diagnostic Validation of Wearable ECG Monitoring Patch, ATP-C120
|
N/A | |
| Completed |
NCT04118270 -
Shared Decision-Making: AFib 2gether Mobile App
|
N/A | |
| Active, not recruiting |
NCT03345615 -
Standard Versus Intensive Monitoring After Myocardial Infarction Looking for Atrial Fibrillation
|
N/A | |
| Not yet recruiting |
NCT05841056 -
Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial
|
Phase 3 | |
| Recruiting |
NCT05149820 -
Point of Care RandOmisation Systems for Performing Embedded Comparative Effectiveness Trials Of Routine Treatments
|
Phase 4 | |
| Completed |
NCT03221777 -
Atrial Fibrillation Occurring Transiently With Stress (AFOTS)
|
||
| Completed |
NCT03118518 -
STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation
|
N/A | |
| Completed |
NCT03552588 -
High Sensitivity Estimate of the Incidence of Atrial Fibrillation Occurring Transiently With Stress (AFOTS Incidence Study)
|
||
| Recruiting |
NCT05444335 -
Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years
|
N/A | |
| Terminated |
NCT05950971 -
Rhythm Control Versus Rate Control for New Onset Atrial Fibrillation
|
N/A | |
| Recruiting |
NCT05287191 -
MAGNAM Trial, Magnesium Versus Amiodarone in Atrial Fribrillation in Critical Care
|
Phase 3 | |
| Recruiting |
NCT05300555 -
Cost-effectiveness Analysis Between Two Anticoagulation Strategies for Atrial Fibrillation in the Postoperative Period of Coronary Artery Bypass Graft Surgery
|
Phase 4 |